Product Launch: China’s First Cheek-Specific Collagen Implant

Event Spotlight: CIFTIS 2025 Headline: Bioregenix Connects with the Global Biomedical Community via High-Quality Chinese Biomaterials Context: Showcasing domestic innovation on the world stage at the

Industry Insights: August Summit Report Headline: Driving Industrial Innovation: Key Takeaways from the Biomedical Industry Summit

Bioregenix's "Collagen Fiber Filler-Ⅱ" Marketing Authorization Application (MAA) Received by NMPA

Regulatory Milestone: NMPA Submission Headline: Marketing Authorization Application (MAA) for "Collagen Fiber Filler-II" Officially Accepted by the NMPA

Forum Invitation Headline: Bioregenix Invited to the 2025 Forum on Collagen Multi-Field Application and Industrialization

Award Recognition Headline: Bioregenix Named a "Top 20 Innovation Leading Enterprise" in the Science Park

Conference Debut: BIA 2025 Headline: Bioregenix Presents at the 2025 BIA Asian Medical Aesthetics & Injection Summit

Brand Update: Digital Presence Headline: Official Launch of the Aikuyan Brand Channel on Xiaohongshu (Little Red Book)

Innovation Showcase Headline: Bioregenix Unveils New Product Portfolio at the 2024 Beijing Changping International Life Science Forum

Regulatory Progress Headline: NMPA Accepts Registration Application for "Collagen Fiber Filler-I"

Industry Honors Headline: Bioregenix Awarded the 2024 "Innovation Potential Enterprise Award" by the Chinese Association of Plastics and Aesthetics (CAPA)

Domestic First-in-Class Achievement Headline: Subject Enrollment Successfully Completed for China’s First Natural Cross-Linked Collagen Fiber Filler (Type III)

Original collagen filler Bai Shuang ® Clinical trial enrollment successfully completed

Trial Initiation: CAMS Plastic Surgery Hospital Headline: Clinical Enrollment Initiated for Innovative Cross-Linked Collagen Filler at the Plastic Surgery Hospital, Chinese Academy of Medical Sciences

Trial Completion: Skin Rejuvenation Therapy Headline: Enrollment Completed for First-in-Class Collagen Mesotherapy Study at the Dermatology Hospital of Southern Medical University

Trial Completion: Guangdong Second Provincial General Hospital Headline: Subject Enrollment Successfully Completed for Proprietary Cross-Linked Collagen Filler Clinical Study